NEW YORK, June 10, 2023 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) is investigating potential claims against Integra LifeSciences Holdings Corp. (“Integra” or the “Company”) (NASDAQ: IART) on behalf of Integra stockholders. All investors who purchased…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.